You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Growth Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

Recruiting
  • Acute Esophageal Variceal Hemorrhage
  • Growth Inhibitor
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Paronychia, Epidermal Growth Factor Receptor Inhibitor Trial in Taipei (Timolol maleate 0.5% ophthalmic solution, Cryotherapy

Recruiting
  • Paronychia
  • Epidermal Growth Factor Receptor Inhibitor
  • Timolol maleate 0.5% ophthalmic solution
  • Cryotherapy with liquid nitrogen
  • Taipei, Taiwan
    Taipei Municipal Wan-Fang Hospital
Jun 7, 2022

Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

Active, not recruiting
  • Metastatic Breast Cancer
  • Hospitalet de Llobregat, Barcelona, Spain
  • +6 more
Jan 23, 2023

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Non Small Cell Lung Cancer Trial in Lyon (Cicaplast Balm B5, Dexeryl)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Cicaplast Balm B5
  • Dexeryl
  • Lyon, Rhône, France
    Centre Léon Bérard
Jul 8, 2021

Retinal Pigment Epithelium Detachment in Neovascular Age-related

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Anti-vascular endothelial growth factor therapy
  • Krasnodar, Russian Federation
    The S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022

Tumor Growth Rate Predicts Clinical Outcomes for Advanced

Recruiting
  • Non-Small Cell Lung Cancer
  • This item is not applicable to our observational study.
  • Guangzhou, Guangdong, China
  • +2 more
Mar 15, 2021

Advanced Breast Cancer Trial in Italy (Abemaciclib, Aromatase Inhibitors)

Recruiting
  • Advanced Breast Cancer
  • Ancona, Italy
  • +43 more
Jan 31, 2022

EGFR Mutant Advanced Non Small Cell Lung Cancer Trial in Australia, Taiwan (Tremelimumab, Durvalumab)

Recruiting
  • EGFR Mutant Advanced Non Small Cell Lung Cancer
  • Bankstown, New South Wales, Australia
  • +17 more
Sep 28, 2021

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Renal Cell Carcinoma Who Received First-Line Sunitinib

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Calgary, Alberta, Canada
    University of Calgary
Feb 19, 2021

NSCLC Trial in GuangZhou (Aprepitant, Desloratadine, Placebo of aprepitant)

Completed
  • Non-small Cell Lung Cancer
  • GuangZhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University (CCSYSU)
May 15, 2021

EGFR Mutation Positive Advanced Non Small Cell Lung Cancer Trial in Worldwide (AZD3759, AZD9291)

Completed
  • EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
  • Los Angeles, California
  • +9 more
Jan 4, 2021

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)

Completed
  • Cardiac Complication
  • Vascular Diseases
  • Cardiac complication induced by VEGF/VEGFR inhibitor
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 24, 2019

Noonan Syndrome Trial in France (Simvastatin, Placebo)

Completed
  • Noonan Syndrome
  • Angers, France
  • +11 more
Nov 14, 2022

Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

Recruiting
  • Cancer of the Colon
  • BLOOD AND TUMOR
  • Marseille, France
    Institut Paoli Calmettes
Jul 12, 2023

Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcoma Trial in United States (Regorafenib, Placebo)

Completed
  • Liposarcoma
  • +4 more
  • Duarte, California
  • +17 more
Oct 25, 2022

Exudative Age-related Macular Degeneration Trial (intravitreal injection)

Completed
  • Exudative Age-related Macular Degeneration
  • intravitreal injection
  • (no location specified)
Apr 19, 2022

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Resistance-associated Mutations in Metastatic Lung Cancer

Recruiting
  • Lung Cancer
  • Liquid biopsy
  • Monza, MB, Italy
    Fondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

Carcinoma, Adenoid Cystic Trial in Qingdao (EGFR-TK Inhibitor)

Recruiting
  • Carcinoma, Adenoid Cystic
  • EGFR-TK Inhibitor
  • Qingdao, Shandong, China
    Qingdao central Hospital
Nov 1, 2021